bf/NASDAQ:CDMO_icon.jpeg

COM:AVIDBIO

Avid Bioservices

  • Stock

USD

Last Close

12.25

22/11 21:00

Market Cap

469.86M

Beta: -

Volume Today

2.17M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '14
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
Apr '24
average inventory
4.93M
-
6.44M
30.55%
11.77M
82.71%
24.64M
109.37%
24.61M
0.12%
11.34M
53.92%
8.72M
23.12%
11.38M
30.47%
18.97M
66.71%
34.98M
84.46%
37.14M
6.16%
average payables
2.63M
-
6.41M
143.94%
9.41M
46.77%
7.10M
24.48%
3.84M
45.89%
3.13M
18.56%
5.14M
64.16%
7.59M
47.72%
9.38M
23.57%
17.05M
81.74%
22.63M
32.74%
average receivables
1.50M
-
2.57M
71.84%
3.34M
29.68%
5.30M
58.89%
5.75M
8.44%
7.73M
34.44%
11.80M
52.75%
18.43M
56.14%
25.43M
38.01%
26.91M
5.80%
28.46M
5.74%
book value per share
2.93
-
2.26
22.82%
1.62
28.40%
1.44
10.91%
1.18
17.98%
0.95
19.96%
0.74
21.54%
1.34
79.50%
2.84
112.60%
3.04
7.20%
0.96
68.34%
capex per share
-0.03
-
-0.35
960.58%
-0.30
13.00%
-0.04
86.60%
-0.06
58.59%
-0.03
58.17%
-0.07
152.24%
-0.17
150.34%
-0.92
441.55%
-1.25
35.90%
-0.50
59.64%
capex to depreciation
-0.77
-
-8.69
1,034.97%
-6.07
30.11%
-0.61
89.97%
-1.18
93.36%
-0.55
53.58%
-1.23
125.47%
-2.86
131.63%
-12.59
340.79%
-10.77
14.48%
-2.86
73.41%
capex to operating cash flow
0.03
-
0.25
839.95%
0.24
6.24%
0.04
83.98%
0.11
198.97%
0.13
14.85%
-0.65
605.02%
-0.32
51.65%
-5.96
1,784.06%
6.02
201.08%
-2.90
148.20%
capex to revenue
-0.03
-
-0.34
902.30%
-0.21
38.23%
-0.03
87.52%
-0.06
116.17%
-0.03
50.23%
-0.06
127.87%
-0.10
61.14%
-0.47
358.42%
-0.52
10.27%
-0.23
56.30%
cash per share
3.36
-
2.61
22.33%
1.99
23.77%
1.26
36.56%
0.90
28.79%
0.58
35.65%
0.64
11.40%
2.92
353.32%
2.05
29.69%
0.62
69.84%
0.60
2.59%
days of inventory on hand
153.96
-
172.14
11.81%
257.25
49.44%
315.77
22.75%
104.11
67.03%
51.60
50.44%
71.23
38.03%
65.10
8.61%
114.68
76.17%
136.06
18.65%
83.62
38.55%
days payables outstanding
67.77
-
243.09
258.72%
133.96
44.89%
55.13
58.84%
12.32
77.65%
34.25
177.94%
38.78
13.24%
50.76
30.88%
41.82
17.62%
76.21
82.23%
56.89
25.35%
days sales outstanding
21.70
-
51.97
139.44%
23.35
55.06%
49.03
109.97%
25.55
47.89%
79.68
211.80%
72.79
8.64%
95.01
30.52%
79.09
16.75%
68.24
13.72%
75.68
10.90%
debt to assets
0.09
-
0.09
4.34%
0.12
40.80%
0.09
26.76%
0.03
70.28%
0.05
73.08%
0.25
438.38%
0.45
78.42%
0.42
4.61%
0.42
1.20%
0.46
10.76%
debt to equity
0.12
-
0.14
18.09%
0.27
85.72%
0.20
25.86%
0.05
76.84%
0.07
48.82%
0.64
836.17%
1.52
137.24%
1.05
31.22%
1.00
4.50%
2.57
157.18%
dividend yield
0.00
-
0.01
1,598.55%
0.05
290.13%
0.03
53.65%
0.03
1.19%
0.02
35.59%
0.01
21.96%
0.00
71.60%
earnings yield
-0.13
-
-0.21
67.41%
-0.74
249.16%
-0.17
77.32%
-0.13
24.27%
-0.02
87.55%
-0.02
34.35%
0.01
142.60%
0.15
1,614.78%
0.00
99.67%
-0.29
57,742.49%
enterprise value
203.66M
-
171.15M
15.96%
14.28M
91.66%
122.05M
754.63%
130.46M
6.89%
235.89M
80.82%
334.18M
41.67%
1.19B
257.45%
883.93M
26.00%
1.26B
42.16%
651.94M
48.12%
enterprise value over ebitda
-5.93
-
-3.47
41.43%
-0.26
92.39%
-4.34
1,542.44%
-6.77
56.09%
-41.96
520.04%
-32.67
22.15%
96.52
395.47%
57.62
40.30%
272.99
373.78%
-86.13
131.55%
ev to operating cash flow
-7.21
-
-4.75
34.08%
-0.36
92.41%
-3.07
750.44%
-4.87
58.88%
-20.34
317.41%
57.35
381.90%
38.31
33.20%
93.39
143.79%
-97.51
204.41%
59.53
161.05%
ev to sales
9.09
-
6.39
29.71%
0.32
95.00%
2.12
562.67%
2.43
14.88%
4.40
80.88%
5.60
27.19%
12.46
122.60%
7.39
40.68%
8.42
13.90%
4.66
44.65%
free cash flow per share
-1.26
-
-1.73
37.50%
-1.58
8.38%
-1.11
29.73%
-0.63
43.12%
-0.23
63.03%
0.04
115.29%
0.37
923.51%
-0.76
308.53%
-1.45
90.40%
-0.33
77.30%
free cash flow yield
-0.10
-
-0.19
82.63%
-0.65
242.93%
-0.24
62.16%
-0.17
29.48%
-0.05
71.68%
0.01
112.01%
0.02
191.68%
-0.06
431.63%
-0.08
44.30%
-0.04
47.17%
graham net net
2.53
-
1.38
45.28%
0.41
70.36%
0.12
69.63%
0.28
123.73%
0.34
22.22%
-0.27
178.62%
0.12
143.54%
-1.57
1,447.96%
-2.89
83.99%
-3.17
9.72%
graham number
10.05
-
9.92
1.37%
8.10
18.27%
4.97
38.74%
3.51
29.22%
1.27
63.94%
1.47
15.86%
2.41
63.81%
11.52
378.80%
0.78
93.19%
6.95
785.50%
income quality
0.80
-
0.72
10.48%
0.71
0.54%
1.41
98.61%
1.23
13.15%
2.75
124.18%
-0.56
120.24%
2.78
599.52%
0.07
97.33%
-23.01
31,141.22%
-0.08
99.66%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-7.14K
-
-50.50K
607.15%
-4.03K
92.03%
-4.04K
0.28%
-764.37
81.07%
1.45
100.19%
7.67
-
4.05
47.13%
-1.00
124.74%
-3.44
242.61%
interest debt per share
0.36
-
0.33
8.90%
0.43
33.10%
0.29
33.98%
0.06
80.81%
-0.00
107.66%
0.48
11,407.85%
2.05
330.04%
3.01
46.94%
3.08
2.27%
2.56
16.88%
inventory turnover
2.37
-
2.12
10.56%
1.42
33.08%
1.16
18.53%
3.51
203.30%
7.07
101.76%
5.12
27.55%
5.61
9.42%
3.18
43.24%
2.68
15.72%
4.37
62.73%
invested capital
0.12
-
0.14
18.09%
0.27
85.72%
0.20
25.86%
0.05
76.84%
0.07
48.82%
0.64
836.17%
1.52
137.24%
1.05
31.22%
1.00
4.50%
2.57
157.18%
market cap
281.15M
-
239.15M
14.94%
75.69M
68.35%
168.85M
123.07%
172.72M
2.29%
268.15M
55.25%
343.59M
28.13%
1.25B
262.71%
827.57M
33.59%
1.11B
33.63%
482.21M
56.40%
net current asset value
62.92M
-
42.09M
33.10%
22.84M
45.74%
24.57M
7.58%
27.80M
13.17%
25.99M
6.52%
-5.96M
122.93%
20.03M
436.02%
-75.29M
475.91%
-149.13M
98.07%
-171.67M
15.11%
net debt to ebitda
2.25
-
1.38
38.84%
1.14
17.68%
1.66
46.45%
2.19
31.88%
5.74
161.71%
0.92
83.97%
-4.18
554.29%
3.67
187.91%
32.74
791.12%
-22.42
168.50%
net income per share
-1.53
-
-1.93
26.04%
-1.80
6.71%
-0.76
57.87%
-0.46
38.92%
-0.08
83.75%
-0.13
71.09%
0.19
249.49%
2.08
978.29%
0.01
99.57%
-2.23
24,864.20%
operating cash flow per share
-1.22
-
-1.38
12.83%
-1.28
7.21%
-1.07
16.34%
-0.57
46.95%
-0.21
63.58%
0.10
149.95%
0.54
417.70%
0.15
71.26%
-0.21
234.44%
0.17
183.73%
payables turnover
5.39
-
1.50
72.12%
2.72
81.46%
6.62
142.98%
29.62
347.41%
10.66
64.02%
9.41
11.69%
7.19
23.60%
8.73
21.38%
4.79
45.12%
6.42
33.96%
receivables turnover
16.82
-
7.02
58.24%
15.63
122.53%
7.44
52.37%
14.28
91.89%
4.58
67.93%
5.01
9.46%
3.84
23.39%
4.61
20.12%
5.35
15.90%
4.82
9.82%
research and ddevelopement to revenue
1.24
-
1.61
29.73%
1.33
17.02%
0.49
63.14%
return on tangible assets
-0.39
-
-0.52
32.30%
-0.51
1.22%
-0.24
53.29%
-0.23
4.45%
-0.05
76.40%
-0.07
25.40%
0.04
162.63%
0.30
603.37%
0.00
99.58%
-0.42
33,785.23%
revenue per share
0.97
-
1.03
5.81%
1.45
40.85%
1.55
7.37%
1.14
26.63%
0.96
15.96%
1.06
10.70%
1.65
55.35%
1.95
18.13%
2.40
23.24%
2.21
7.65%
roe
-0.52
-
-0.85
63.31%
-1.11
30.29%
-0.53
52.71%
-0.39
25.53%
-0.08
79.70%
-0.17
118.05%
0.14
183.28%
0.73
407.19%
0.00
99.60%
-2.31
78,311.61%
roic
-0.47
-
-0.75
57.94%
-0.90
19.95%
-0.40
55.16%
-0.33
17.70%
-0.09
71.76%
-0.08
14.16%
0.05
161.50%
0.27
453.41%
-0.00
100.62%
-0.45
26,243.07%
sales general and administrative to revenue
shareholders equity per share
2.93
-
2.26
22.82%
1.62
28.40%
1.44
10.91%
1.18
17.98%
0.95
19.96%
0.74
21.54%
1.34
79.50%
2.84
112.60%
3.04
7.20%
0.96
68.34%
stock based compensation to revenue
0.28
-
0.25
9.68%
0.11
56.20%
0.06
46.76%
0.03
50.85%
0.03
3.74%
0.04
40.67%
0.04
3.96%
0.06
53.50%
0.07
19.19%
tangible asset value
67.70M
-
59.03M
12.80%
50.07M
15.18%
53.58M
7.01%
55.74M
4.02%
53.07M
4.79%
41.90M
21.05%
77.74M
85.55%
174.53M
124.51%
189.47M
8.56%
60.89M
67.86%
tangible book value per share
2.93
-
2.26
22.82%
1.62
28.40%
1.44
10.91%
1.18
17.98%
0.95
19.96%
0.74
21.54%
1.34
79.50%
2.84
112.60%
3.04
7.20%
0.96
68.34%
working capital
63.56M
-
43.19M
32.05%
24.23M
43.89%
26.17M
7.98%
29.96M
14.50%
28.16M
6.03%
15.28M
45.72%
136.87M
795.56%
104.26M
23.82%
38.74M
62.84%
33.44M
13.70%

All numbers in USD (except ratios and percentages)